Skip to main content

Table 1 Overview assessment of questionnaires and collection of body material and medical files per time point

From: Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double-blind, controlled clinical trial

 

T0

IP a

T1

T2

T3

T4

T5

T6

T7

Questionnaires

 SIGH-SAD

X

X

X

X

X

 

X

X

X

 EPDS

X

X

X

X

X

 

X

X

X

 Life events

X

X

X

X

X

 

X

X

X

 PSQI

X

X

X

X

X

 

X

  

 User expectations

X

        

 User experiences

  

X

   

X

  

 MABS

      

X

  

 CBCL

        

X

Body material

 Urine cortisol

X

 

X

X

  

X

  

 Saliva cortisol/melatonin

X

 

X

X

  

X

  

 Hair cortisol

X

   

X

 

X

  

 Saliva cortisol (infant)

      

X

  

 Hair cortisol (infant)

      

X

  

Actigraphy

X b

   

X c

 

X c

  

Collecting medical files

     

X

   
  1. T0 baseline (start of treatment), T1 after 6 weeks of treatment (end of treatment), T2 = 3 weeks after treatment, T3 = 10 weeks after treatment, T4 birth, T5 2 months postpartum, IP intervention period, SIGH-SAD Structured Interview Guide for the Hamilton Depression Scale – Seasonal Affective Disorder version, EPDS Edinburgh Postnatal Depression Scale, PSQI Pittsburgh Sleep Quality Index, MABS Mother and Baby Scales, CBCL Child Behaviour Checklist
  2. aIn the intervention period, the questionnaires will be assessed weekly
  3. bThe actiwatch needs to be worn for 8 weeks at T0
  4. cAt T3 and T5, the actiwatch needs to be worn for 9 days
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us